Oncologists near Hackensack, NJ

Biography: Paul Chapman, MD is currently the Chief Medical Research Officer for the Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Chapman received his M.D. degree from Weill Cornell Medical College in 1981 and trained in internal medicine as an intern and resident at the University of Chicago Hospitals and Clinics from 1981-1984. After that, he returned to New York as a medical oncology Fellow at Memorial Sloan Kettering Cancer where he focused on immunotherapy of melanoma in the laboratory of Dr. Alan Houghton. He joined the faculty of Memorial Sloan Kettering Cancer Center (MSKCC) in 1988 and worked there through 2023 as a tenured Attending Physician. During this time at MSKCC, Dr. Chapman led many clinical and laboratory studies designed to develop new and improved treatments for melanoma. This included the first BRAF targeted therapy trial and several immunotherapy trials. His research continues to focus on developing new treatments for melanoma.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Maria Garzon, M.D. is Professor of Dermatology and Pediatrics at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and the Director of the Division of Pediatric Dermatology at NYP Morgan Stanley Children's Hospital. With a significant body of published research, leadership and teaching experience, Dr. Garzon is an internationally recognized leader in pediatric dermatology. She is a leading expert on the care of children and adolescents with vascular anomalies, particularly hemangiomas and vascular malformations. Dr. Garzon is the Founder and Co-Director of the NYP/Columbia University Irving Medical Center (NYP/CUIMC) Interdisciplinary Vascular Anomalies Group, a founding member and past President of the Hemangioma Investigator Group (HIG) and a founding member of the Pediatric Dermatology Research Alliance (PeDRA). She is a past President of both the Society for Pediatric Dermatology and the New York Dermatological Society. She was elected to the Academy of Clinical Excellence (ACE) at VP&S and named a Samberg Scholar at NYP Morgan Stanley Children's Hospital. Dr. Garzon has authored numerous articles and book chapters and has lectured at many national and international meetings including the American Academy of Dermatology, American Academy of Pediatrics, Pediatric Academic Societies, World Congress of Pediatric Dermatology, National Institute of Health and International Society for the Study of Vascular Anomalies. Dr. Garzon has been named a top doctor by Castle Connolly, Best Doctors and New York Magazine.Dr. Garzon received her undergraduate degree from Harvard University and her medical degree from Columbia University College of Physicians and Surgeons where she was elected to Alpha Omega Alpha Honor Society. She completed her Pediatric residency at the former Babies Hospital, Columbia Presbyterian Medical Center (now New York-Presbyterian Morgan Stanley Children's Hospital) and dermatology residency at NYP Columbia University Medical Center. She was a fellow in pediatric dermatology at Children's Memorial Hospital, Northwestern University in Chicago, IL. She is a fellow of the American Academy of Dermatology and American Academy of Pediatrics and a member of the Society for Pediatric Dermatology, American Dermatologic Association, Hemangioma Investigator Group, International Society for the Study of Vascular Anomalies, Pediatric Dermatology Research Alliance, Society for Investigative Dermatology, and Women's Dermatologic Society.

Biography: I am a board-certified medical oncologist specializing in the treatment of thoracic malignancies. I received my undergraduate degree from Princeton University, an MD from the combined Harvard Medical School and MIT Program in Health Sciences and Technology (HST), and an MSc in the History of Science and Medicine from Imperial College, London. I completed my internship and residency training in internal medicine at Massachusetts General Hospital, where I was a Stanbury Physician-Scientist trainee, and my fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center, where I was Chief Fellow. I see patients with all types of thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, mesothelioma and thymoma. As someone whose own life was touched by cancer diagnoses, I work with a team of specialists to bring individual, compassionate care to each of my patients. My research interests are in lung cancer and cancers with special difficulties repairing damage to their DNA. I develop clinical trials using novel agents targeting DNA repair, bringing these drugs directly to my patients in the clinic. My laboratory work aims to define new vulnerabilities in cancer cells which can be leveraged for more effective, less toxic therapy. This work has been recognized by several awards from the NIH and other organizations.

Biography: Dr. Charles Shapiro, MD is a Hematology Specialist who practices in New York, NY. He is 68 years old and has been practicing for 41 years. Dr. Charles Shapiro, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Lewis Silverman, MD is an Oncology Specialist who practices in New York, NY. He is 75 years old and has been practicing for 47 years. Dr. Lewis Silverman, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Said Saleh, MD is a Hematology Specialist who practices in Montclair, NJ. He is 60 years old. Dr. Said Saleh, MD is affiliated with Clara Maass Medical Center and Cooperman Barnabas Medical Center.

Biography: Dr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York, NY. She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010. Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards.

Biography: Dr. Spiros Hiotis, MD is a Complex General Surgical Oncology Specialist who practices in New York, NY. He is 58 years old. Dr. Spiros Hiotis, MD is affiliated with Mount Sinai Hospital, Mount Sinai Morningside and Mount Sinai Queens.

Care Philosophy: I have expertise in stem cell / bone marrow transplantation, with over 25 years of experience in this field. I am the Associate Director of the Blood and Bone Marrow Transplant Program of New York Presbyterian Hospital - Cornell. and the Service Chief of the inpatient BMT clinical service. I have major interests in improving the overall safety and effectiveness of transplantation. I also have significant experience in the management of hematological malignancies such as leukemia, lymphoma, myeloma, myelodysplasia, as well as aplastic anemia. I enjoy teaching residents and fellows management of patients undergoing transplantation and I have published articles in this field. I also review articles for medical journals relating to stem cell transplantation.I am involved in multiple research trials related to BMT, both as a principal and co investigator and I have represented NYP Weill Cornell at the Cancer Alliance Clinical Trials Group, the Myeloproliferative Disease Research group, and the BMT Clinical Trials Network. However, my main love is caring for patients; I enjoy meeting them, guiding them through the transplant process, and having a true doctor patient relationship. I am committed to providing the best possible, state of the art care for my patients, with clear explanations and ongoing personal support through difficult situations.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Jedd Wolchok, MD, PhD, FASCO, is the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. Dr. Wolchok was most recently Chief of the Immuno-Oncology Service and held The Lloyd J. Old Chair in Clinical Investigation at Memorial Sloan Kettering Cancer Center and remains Professor of Medicine at Weill Cornell Medical College. Dr. Wolchok is a clinician-scientist exploring innovative immunotherapeutic strategies in laboratory models, and a principal investigator in numerous pivotal clinical trials. Dr. Wolchok helped establish immunotherapy as a standard approach to cancer treatment and was instrumental in the clinical development leading to the approval of ipilimumab and the combination of nivolumab and ipilimumab for advanced melanoma. He supervises an NIH R01-funded basic science laboratory which is focused on investigating novel immunotherapeutic agents in pre-clinical laboratory models. The focus of his translational research laboratory is to investigate innovative means to modulate the immune response to cancer as well as to better understand the mechanistic basis for sensitivity and resistance to currently available immunotherapies. Dr. Wolchok received his BA degree from Princeton University, and his MS, PhD and MD degrees from New York University. Dr. Wolchok has received numerous honors for his work including: American Association for Cancer Research (AACR) Richard and Hinda Rosenthal Memorial Award, the Giants of Cancer Care in Melanoma Award, the Berson Alumni Achievement Award in Clinical and Translational Science and the Zelmanovich Young Alumni Achievement Award from NYU Grossman School of Medicine, the Alfred Taubman Prize for Excellence in Translational Medical Research (Univ of Michigan) and has been designated a Fellow of the American Society of Clinical Oncology (FASCO). Most recently, he has been awarded the the Distinguished Alumni Award at MSK, the AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research, the ESMO Award for Immuno-Oncology and the David Karnofsky Award from ASCO. Dr. Wolchok has served on the Board of Directors of ASCO and the Society for Immunotherapy of Cancer (SITC) and currently is the Treasurer of SITC. He is an elected member of the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP) and is Chair of the Melanoma Committee for the ECOG-ACRIN NCI cooperative group. He is a full member of the Ludwig Institute for Cancer Research and center director for the Parker Institute of Cancer Immunotherapy.

Care Philosophy: My clinical interests include working with children with various blood disorders, such as sickle cell anemia, blood clotting disorders, and rare disorders called Myeloproliferative Neoplasms. I find it a privilege to be able to help families deal with their children's complex medical issues. By combining excellent, compassionate medical care with research aimed at improving outcomes and preventing disease-associated complications, I believe that we can make a difference for children with cancer and blood disorders.